Casdin Capital, LLC Tenaya Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $1.16 Billion
- Q2 2024
A detailed history of Casdin Capital, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 6,732,971 shares of TNYA stock, worth $13.7 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
6,732,971
Previous 6,732,971
-0.0%
Holding current value
$13.7 Million
Previous $20.9 Million
-0.0%
% of portfolio
1.8%
Previous 1.81%
Shares
4 transactions
Others Institutions Holding TNYA
# of Institutions
98Shares Held
55.6MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$19.2 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$15.5 Million0.36% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$8.31 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$7.17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$6.46 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $84.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...